Curaleaf Reports Third Quarter 2025 Results: Solid Growth and Robust Cash Generation
Executive Summary
- Curaleaf reported Q3 2025 net revenue of $320.2 M (‑3% YoY, +2% sequential), with adjusted gross profit margin improving to 50%.
- Adjusted EBITDA was $69.3 M (21.6% margin) and operating cash flow from continuing operations reached $53 M; free cash flow was $37 M.
- The company upsized its revolving credit facility to $100 M, completed the final payment on the Tryke acquisition, and announced a 100% ownership of its European holding company.
Key Details
- Financial Highlights – Q3 2025
- Net revenue: $320.2 M (‑3% YoY, +2% QoQ)
- Gross profit: $159.7 M; gross margin 50% (+130 bps YoY)
- Adjusted gross profit: $160.0 M; adjusted gross margin 50% (+115 bps YoY)
- Net loss (continuing): $54.5 M ($0.07 per share)
- Adjusted net loss (continuing): $48.2 M ($0.06 per share)
- Adjusted EBITDA: $69.3 M; margin 21.6% (‑115 bps YoY)
-
Cash at quarter end: $107.5 M
-
Nine‑Month Highlights – ended Sep 30 2025
- Net revenue: $944.8 M (‑7% YoY)
- International revenue: $121.8 M (+63% YoY)
- Adjusted EBITDA: $200.0 M; margin 21.2% (‑100 bps YoY)
- Operating cash flow (continuing): $104.0 M
-
Free cash flow (continuing): $56.8 M
-
Operational Updates
- Domestic retail footprint expanded to 5 stores in Ohio, added two Florida locations (total FL stores = 69).
- Total dispensary count at quarter‑end: 158 U.S. stores.
- Launched Anthem Bold Infused Pre‑Rolls in NY, NJ, IL, AZ.
- Added to S&P/TSX Composite Index on Sep 22 2025.
- Completed buyout of minority partner in Curaleaf International – now 100% owned.
-
Curaleaf International introduced the QMID liquid inhalation device in UK & Germany.
-
Financing Activity
- Upsized revolving line of credit with Needham Bank from $40 M to $100 M at 7.99% (rising to 8.99% upon senior bond refinancing).
-
Made final $25 M cash + 5.7 M share payment to former Tryke owners, completing the acquisition consideration.
-
Balance Sheet
- Cash & equivalents: $107.5 M; total debt (net of discounts/fees): $543.7 M.
-
Shareholders’ equity: $814.8 M.
-
Conference Call
- Date/time: Wed, 2025‑11‑05 at 17:00 ET. Dial‑in numbers and webcast details provided.
Notable Quotes
“We generated third quarter revenue of $320 million, up 2% sequentially… Adjusted gross margin improved to 50%, an increase of 115 basis points both sequentially and versus the prior year.” – Boris Jordan, Chairman & CEO
Materiality Assessment: Material – Neutral (the release contains comprehensive financial results and significant operational/financing updates that are material to investors).